- Home
- BOLT vs DXST Comparison
BOLT vs DXST Comparison
Compare BOLT & DXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLT
- DXST
- Stock Information
- Founded
- BOLT 2015
- DXST 2011
- Country
- BOLT United States
- DXST China
- Employees
- BOLT N/A
- DXST N/A
- Industry
- BOLT Biotechnology: Pharmaceutical Preparations
- DXST
- Sector
- BOLT Health Care
- DXST
- Exchange
- BOLT Nasdaq
- DXST NYSE
- Market Cap
- BOLT 16.8M
- DXST 18.7M
- IPO Year
- BOLT 2021
- DXST 2025
- Fundamental
- Price
- BOLT $5.63
- DXST $1.34
- Analyst Decision
- BOLT Buy
- DXST
- Analyst Count
- BOLT 3
- DXST 0
- Target Price
- BOLT $50.00
- DXST N/A
- AVG Volume (30 Days)
- BOLT 19.4K
- DXST 32.1K
- Earning Date
- BOLT 08-12-2025
- DXST 01-01-0001
- Dividend Yield
- BOLT N/A
- DXST N/A
- EPS Growth
- BOLT N/A
- DXST 13.11
- EPS
- BOLT N/A
- DXST 0.14
- Revenue
- BOLT $3,638,000.00
- DXST $11,542,292.00
- Revenue This Year
- BOLT N/A
- DXST N/A
- Revenue Next Year
- BOLT $24.14
- DXST N/A
- P/E Ratio
- BOLT N/A
- DXST $9.63
- Revenue Growth
- BOLT N/A
- DXST 22.18
- 52 Week Low
- BOLT $5.20
- DXST $0.85
- 52 Week High
- BOLT $15.60
- DXST $5.74
- Technical
- Relative Strength Index (RSI)
- BOLT 43.75
- DXST N/A
- Support Level
- BOLT $5.62
- DXST N/A
- Resistance Level
- BOLT $6.40
- DXST N/A
- Average True Range (ATR)
- BOLT 0.29
- DXST 0.00
- MACD
- BOLT 0.01
- DXST 0.00
- Stochastic Oscillator
- BOLT 25.00
- DXST 0.00
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
About DXST DECENT HOLDING INC
Decent Holding Inc through its subsidiary specializes in the provision of wastewater treatment by cleansing the industrial wastewater, ecological river restoration and river ecosystem management by enhancing the water quality, as well as microbial products used for pollutant removal and water quality enhancement. Its main services and products include (1) wastewater treatment, (2) river water quality management, and (3) microbial products for water quality enhancement and pollutant cleansing purposes. The company's focus is on research and development (R&D) to sharpen its innovation edge.